Journal: ACS Infectious Diseases
Article Title: Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses
doi: 10.1021/acsinfecdis.1c00631
Figure Lengend Snippet: Inhibitor-binding pocket of three subgroup 2b viruses. (A) F o – F c electron density composite omit map is shown contoured at 3σ (green mesh). With GRL0617 shown in purple and BtSCoV-Rf1 PLpro shown in green. (B) GRL0617 (purple) bound to BtSCoV-Rf1 PLpro (green cartoon) overlaid with SARS-CoV-2 (white surface and cartoon) showing a possible path to active site for future inhibitors. (C) Stereoview overlay of GRL0617 bound to three different SARS-CoV PLpros: BtSCoV-Rf1 (green and purple) (PDB 7SKQ), SARS-CoV-1 (pink and orange) (PDB 3E9S), and SARS-CoV-2 (blue and yellow) (PDB 7JIR).
Article Snippet: 5-Amino-2-methyl-N-[( R )-1-(1-naphthyl)ethyl]benzamide ( GRL0617 ) was purchased from Raystar, CN; 5-(acetylamino)-2-methyl- N -[(1 R )-1-(1-napthanlenyl)ethyl]-benzamide (compound 6) was purchased from MedChem Express; Z-RLRGG-7-amino-4-methyl-courmarin (peptide-AMC) was purchased from Bachem; Ub-AMC was purchased from Boston Biochem; human ISG15-AMC was purchased from Boston Biochem; Lys6, Lys11, Lys29, Lys33, Lys48, Lys63, and linear linked di-Ub were obtained from Boston Biochem; DL-dithiothroitol (DTT) was purchased from GoldBio; Isopropyl β-D-thiogalactopyranoside (IPTG) was purchased from GoldBio; 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) was purchased from Fisher BioReagents; imidazole was purchased from Acros Organics; tris(hydroxymethyl)aminomethane (Tris) was purchased from Fisher Scientific; sodium chloride (NaCl) was purchased from Fisher Chemical; bovine serum albumin (BSA) was purchased from Sigma Life Science; dehydrated Luria–Bertani (LB) broth was purchased from Fisher Scientific; ampicillin was purchased from GoldBio.
Techniques: Binding Assay